These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9414145)

  • 1. KF19514, a phosphodieterase 4 and 1 inhibitor, inhibits PAF-induced lung inflammatory responses by inhaled administration in guinea pigs.
    Manabe H; Akuta K; Okamura K; Ohmori K
    Int Arch Allergy Immunol; 1997 Dec; 114(4):389-99. PubMed ID: 9414145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs.
    Manabe H; Akuta K; Kawasaki H; Ohmori K
    Pulm Pharmacol Ther; 2000; 13(1):5-11. PubMed ID: 10718985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory and bronchodilator properties of KF19514, a phosphodiesterase 4 and 1 inhibitor.
    Manabe H; Akuta K; Sejimo H; Kawasaki H; Nukui E; Ichimura M; Kase H; Kawakita T; Suzuki F; Kitamura S; Sato S; Ohmori K
    Eur J Pharmacol; 1997 Jul; 332(1):97-107. PubMed ID: 9298930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoprotective effect of an intrabronchial administration of cilostazol powder and a nebulized PDE1 and PDE4 inhibitor KF19514 in guinea pigs.
    Fujimura M; Tachibana H; Myou S; Kita T; Matsuda T
    Int Arch Allergy Immunol; 1998 Jul; 116(3):220-7. PubMed ID: 9693270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aerosolized administration of KF19514, a phosphodiesterase 4 inhibitor, on bronchial hyperresponsiveness and airway inflammation induced by antigen inhalation in guinea-pigs.
    Myou S; Fujimura M; Kurashima K; Tachibana H; Hirose T; Nakao S
    Clin Exp Allergy; 2000 May; 30(5):713-8. PubMed ID: 10792364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma.
    Torphy TJ; Barnette MS; Hay DW; Underwood DC
    Environ Health Perspect; 1994 Dec; 102 Suppl 10(Suppl 10):79-84. PubMed ID: 7705312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor.
    Raeburn D; Underwood SL; Lewis SA; Woodman VR; Battram CH; Tomkinson A; Sharma S; Jordan R; Souness JE; Webber SE
    Br J Pharmacol; 1994 Dec; 113(4):1423-31. PubMed ID: 7889300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
    Hughes B; Howat D; Lisle H; Holbrook M; James T; Gozzard N; Blease K; Hughes P; Kingaby R; Warrellow G; Alexander R; Head J; Boyd E; Eaton M; Perry M; Wales M; Smith B; Owens R; Catterall C; Lumb S; Russell A; Allen R; Merriman M; Bloxham D; Higgs G
    Br J Pharmacol; 1996 Jul; 118(5):1183-91. PubMed ID: 8818342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs.
    Ortiz JL; Vallés JM; Martí-Cabrera M; Cortijo J; Morcillo EJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):200-6. PubMed ID: 8717161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.
    Souness JE; Maslen C; Webber S; Foster M; Raeburn D; Palfreyman MN; Ashton MJ; Karlsson JA
    Br J Pharmacol; 1995 May; 115(1):39-46. PubMed ID: 7647982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs.
    Santing RE; Olymulder CG; Van der Molen K; Meurs H; Zaagsma J
    Eur J Pharmacol; 1995 Feb; 275(1):75-82. PubMed ID: 7774665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor.
    Holbrook M; Gozzard N; James T; Higgs G; Hughes B
    Br J Pharmacol; 1996 Jul; 118(5):1192-200. PubMed ID: 8818343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention by phosphodiesterase inhibitors of antigen-induced contraction of guinea-pig colonic smooth muscle.
    Grous M; Barnette M
    Br J Pharmacol; 1994 Jan; 111(1):259-63. PubMed ID: 7516803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
    Underwood DC; Osborn RR; Novak LB; Matthews JK; Newsholme SJ; Undem BJ; Hand JM; Torphy TJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):306-13. PubMed ID: 8392555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
    Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D
    Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim.
    Cortijo J; Villagrasa V; Navarrete C; Sanz C; Berto L; Michel A; Bonnet PA; Morcillo EJ
    Br J Pharmacol; 1996 Sep; 119(1):99-106. PubMed ID: 8872362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of KF19514, a phosphodiesterase 4 and 1 Inhibitor, on bronchial inflammation and remodeling in a murine model of chronic asthma.
    Kita T; Fujimura M; Myou S; Watanabe K; Waseda Y; Nakao S
    Allergol Int; 2009 Jun; 58(2):267-75. PubMed ID: 19390238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma and airway inflammation: potential anti-inflammatory activities of phosphodiesterase inhibitors.
    Lagente V; Hichami A; Boichot E; Martins MA; Silva PM
    Allerg Immunol (Paris); 1995 Feb; 27(2):34-9. PubMed ID: 7710653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
    Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
    Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
    Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.